Debt-to-equity of Semnur Pharmaceuticals, Inc. from 31 Mar 2023 to 31 Dec 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Semnur Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2023 to 31 Dec 2025.
Semnur Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was -48%, a 3.2% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Semnur Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q4 2025	-48%	-1.5%	-3.2%	31 Dec 2025
Q3 2025	-60%	-37%	-166%	30 Sep 2025
Q2 2025	-47%	-19%	-71%	30 Jun 2025
Q1 2025	-47%	-12%	-35%	31 Mar 2025
Q4 2024	-47%	+3.4%	+6.9%	31 Dec 2024
Q3 2024	-22%	+85%	+79%	30 Sep 2024
Q2 2024	-27%	+89%	+76%	30 Jun 2024
Q1 2024	-35%	+99%	+74%	31 Mar 2024
Q4 2023	-50%			31 Dec 2023
Q3 2023	-107%			30 Sep 2023
Q2 2023	-116%			30 Jun 2023
Q1 2023	-134%			31 Mar 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.